Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 Results
Advancing investigation of [212Pb]VMT01 as a monotherapy and in combination with the anti-PD-1 antibody, nivolumab, in patients with previously ...
Business Insider31m
Peyto Reports Strong Third Quarter Results and Preliminary 2025 Capital Program
The results to date from these wells have been excellent and the team has identified at least another 20 locations ... Conference Call and Webcast A conference call will be held with senior management ...